Canada’s patchwork of private drug plans will leave Canadians with less coverage and more regional disparities, cautions a new study. A report by the Institute for Research On Public Policy said provincial drug plans are inconsistent and vary widely by cost: ‘These may not be the improvements people are looking for’.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
